InsidersTradesSigma
Explore the complete record of transactions filed by Jalota Deepika, SVP, Affaires Réglementaires et QA. Director active across 1 company, notably PMV Pharmaceuticals, Inc.. In total, 2 disclosures have been published. History available since 17 August 2021. The latest transaction was disclosed on 17 August 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Deepika Jalota is the Senior Vice President of Regulatory Affairs and Quality Assurance at PMV Pharmaceuticals, Inc. She oversees regulatory and quality activities, ensuring that the company's products meet industry standards. Her expertise is essential for the company's success.